LncRNA PVT1 regulates CD4 + T cell dysregulation in systemic lupus erythematosus: insights from human patients and MRL/lpr mouse
Clinical Rheumatology · 2025
DOI: 10.1007/s10067-025-07519-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Rheumatology, 2025. Verfasst von Jiali Zhang und 19 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Dermatology and Department of Dermatology, the First Affiliated Hospital, Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, RNA, Long Noncoding, CD4-Positive T-Lymphocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science Fund for Distinguished Young Scholars of Anhui Province, Grants for Scientific Research of BSKY from Anhui Medical University.
Abstract (Originalsprache)
Objectives
To investigate the role of lncRNA PVT1 in modulating CD4 + T cell subsets and its contribution to systemic lupus erythematosus (SLE) pathogenesis in human patients and MRL/lpr mice.
Methods
Measured PVT1 and miR-30e-5p expression in SLE patients ( n = 65) and healthy controls (HCs) using qRT-PCR. Analyzed Th1/Th2/Th17/Treg cell frequencies by flow cytometry and cytokine levels (IL-2, IL-4, IL-6, IL-17, TGF-β) via ELISA. Constructed lentiviral vectors to silence (SLE + si- Pvt1 ) or overexpress Pvt1 (SLE + lenti- Pvt1 ) in MRL/lpr mice ( n = 40).
Results
PVT1 was upregulated ( p = 0.0488) and miR-30e-5p downregulated ( p = 0.0095) in SLE patients. Th2 ( p = 0.0165) and Th17 ( p = 0.0017) cells exhibited a significant increase, while Th1 and Treg cells decreased. Pvt1 silencing reversed SLE phenotypes, increasing Th1 and Treg cells, reducing Th2 and Th17 cells, restoring IL-2 and TGF-β levels and reducing levels of IL-6 and IL-17. Overexpression of Pvt1 exacerbated disease severity. Pvt1 acted as a ceRNA to sponge miR-30e-5p, modulating T-bet/GATA3/RORγt/Foxp3 expression.
Conclusions
PVT1 dysregulation disrupts CD4 + T cell homeostasis in SLE. Targeting the PVT1/miR-30e-5p axis may restore immune balance and represent a novel therapeutic strategy. Key Points • Our data confirm the imbalance of CD4+ T cell subsets in SLE patients and demonstrate specific upregulation of lncRNA PVT1 expression in female SLE patients. • Targeting lncRNA PVT1 affects Th1/Th2 and Th17/Treg homeostasis in MRL/lpr mice. • Offers fresh insight into the dysregulation of lymphocyte subsets in SLE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Dermatology and Department of Dermatology, the First Affiliated Hospital, Anhui Medical University, Hefei, China.
- Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, Hefei, China.
- First Clinical Medical College, Anhui Medical University, Hefei, China.
- Department of Dermatology, Shannan People's Hospital, Shannan, China.
- Department of Dermatology, Friendship Hospital, Beijing, China.
- Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China.
Förderung
- National Natural Science Foundation of China
- Science Fund for Distinguished Young Scholars of Anhui Province
- Grants for Scientific Research of BSKY from Anhui Medical University
- Female Center for Scientific and Medical Colleges, King Saud University
- The key Project of Natural Science Research Projects of Anhui Higher Education Institutions
- Anhui Provincial Institute of Translational Medicine
- The College Students' Innovative Entrepreneurial Training Plan Program
- National Outstanding Youth Science Fund Project of National Natural Science Foundation of China
Zitieren
APA
Zhang, J., Yuan, Y., Ni, S., Mu, S., Wang, W., Sun, F., Liang, B., Lu, P., Qiu, Y., Du, W., Wang, C., Duan, H., Hu, Z., Wen, L., Zheng, X., Sheng, Y., Zhang, S., Chen, S., Yin, X., & Zhu, Z. (2025). LncRNA PVT1 regulates CD4 + T cell dysregulation in systemic lupus erythematosus: insights from human patients and MRL/lpr mouse. Clinical Rheumatology. https://doi.org/10.1007/s10067-025-07519-4
Vancouver
Zhang J, Yuan Y, Ni S, Mu S, Wang W, Sun F, et al. LncRNA PVT1 regulates CD4 + T cell dysregulation in systemic lupus erythematosus: insights from human patients and MRL/lpr mouse. Clinical Rheumatology. 2025. doi:10.1007/s10067-025-07519-4
BibTeX
@article{Zhang2025,
author = {Zhang, Jiali and Yuan, Ying and Ni, Shuangying and Mu, Siqi and Wang, Wanrong and Sun, Feiyang and Liang, Bo and Lu, Peng and Qiu, Yue and Du, Wenhui and Wang, Chenjun and Duan, Huijie and Hu, Zejuan and Wen, Leilei and Zheng, Xiaodong and Sheng, Yujun and Zhang, Shengquan and Chen, Shanyu and Yin, Xueli and Zhu, Zhengwei},
title = {LncRNA PVT1 regulates CD4 + T cell dysregulation in systemic lupus erythematosus: insights from human patients and MRL/lpr mouse},
journal = {Clinical Rheumatology},
year = {2025},
doi = {10.1007/s10067-025-07519-4}
}
EUVIMED